Pilot Research on Urinary Tract Infections in Family Medicine Physician Offices in the Republic of Croatia
V. Škerk,J. Jakšicg,J. Begovac
DOI: https://doi.org/10.1179/joc.2008.20.3.397
2008-06-01
Journal of Chemotherapy
Abstract:Urinary tract infections (UTI) comprise a heterogeneous group of clinical syndromes and diseases ranging from asymptomatic bacteriuria to acute pyelonephritis with urosepsis. UTIs are the most common bacterial infections in humans and one of the most common reasons for prescribing antimicrobial drugs.1 According to the data from the Croatian National Institute of Public Health, there were 531,331 diseases of urinary tract and genital organs, among which 246,353 cases of urinary bladder inflammations, recorded at the primary health care offices in the Republic of Croatia in 2005.2 The aim of this prospective pilot study was to investigate the epidemiology, etiology, clinical presentation and the treatment of UTIs among outpatients in the Republic of Croatia. In the period from October 1, 2006 until November 30, 2006 we investigated a total of 604 episodes of UTI recorded in 20 primary health care offices in the cities of Karlovac, Labin, Pula, Rijeka, Split and Zagreb. Each episode was attributed to one patient. The data were collected according to a specially designed questionnaire filled out at the time of the patient’s arrival to general physician’s office. Data analysis was performed by using Microsoft Access, descriptive statistics and Mann Whitney test. A total of 124 episodes were recorded among males and 480 among females. Median age in males was 57.1±18.3 years, ranging from 17 to 83 years. Median age in females was 54.5±18.2 years, ranging from 17 to 84 years. There was no statistically significant difference recorded between age in males and females with UTI. More than half of the UTIs in women (59%) and males (65%) were recorded in the age group 50-79 years. In males, prostatitis was most frequently recorded (48%), followed by urethritis (16%), cystitis (8%), recurrent pyelonephritis (6%). The most common UTIs in women were acute uncomplicated cystitis (62%), recurrent cystitis (16%), acute uncomplicated pyelonephritis (6%), asymptomatic bacteriuria (5%) and recurrent pyelonephritis (2%) (Table 1). In 22% of males and 9% of females a UTI was complicated by urolithiasis, urinary catheter, urinary incontinence, anatomically or functionally abnormal urinary tract, urinary tract surgery in the last month or uterine prolapse. Diabetes was recorded in 17% (83/480) of females and 12% (15/124) of males with a UTI. In 25% (120/480) of women and in 15% (18/124) of men the symptoms of urinary tract infection lasted more than 7 days prior to their visit to the general practitioner. Etiological diagnosis was made in 223 (37%) UTI episodes before antimicrobial therapy was given. The most frequently isolated causative pathogens were Escherichia coli (170; 76.2%), Enterococcus (18; 8.1%), Streptococcus agalactiae (15; 6.7%) and Proteus mirabilis (11; 4.9%). Antimicrobial drug was administered in all 604 episodes of UTI, in 381 (63.1%) as empirical therapy, and in 223 (36.95) as targeted antimicrobial therapy. The following antibiotics were used: cephalexin in 580 episodes, co-amoxiclav in 10, norfloxacin in 6 and nitrofurantoin in 8 episodes. Since 1997, the resistance of bacterial pathogens to antibiotics, in the most common clinical syndromes, has been regularly monitored in Croatia.3 National guidelines for antimicrobial treatment and prophylaxis of UTI were published in 2004.4 The results of this research cannot precisely answer the question to what extent administered antimicrobial therapy corresponds to recommended antimicrobial therapy, published in the National guidelines for antimicrobial treatment and prophylaxis of UTI. But by comparing various clinically determined UTI categories and administered antibiotics, it is clear that antimicrobial therapy often was inadequately prescribed and that Croatia needs rapid popularization and general adoption of the National guidelines for antimicrobial treatment of UTI.